Peripheral Neuropathies in Human Immunodeficiency Virus Infection

Peripheral Neuropathy

Volumn 2, Issue , 2005, Pages 2129-2145

  Höke, Ahmet ^a   Cornblath, David R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 29744435759     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9491-7.50097-1     Document Type: Chapter

References (188)

1. Alliegro M.B., Petrucci A., Arpino C., et al. Peripheral neuropathies among patients with HIV infection. J. Neurol. Neurosurg. Psychiatry 1998, 64:414.
2. Anders H.J., Weiss N., Bogner J.R., et al. Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradicu-lopathy. J. Infect. 1998, 36:29.
3. Anderson T.D., Davidovich A., Arceo R., et al. Peripheral neuropathy induced by 2', 3'-dideoxycytidine: a rabbit model of 2', 3'-dideoxycytidine neurotoxicity. Lab. Invest. 1992, 66:63.
4. Anderson T.D., Davidovich A., Feldman D., et al. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity. Lab. Invest. 1994, 70:724.
5. Anonymous Testing for neurological involvement in HIV infection. Lancet 1987, 2:1531.
6. Apostolski S., McAlarney T., Hays A.P., et al. Complement dependent cytotoxicity of sensory ganglion neurons mediated by the gp120 glycoprotein of HIV-1. Immunol. Invest. 1994, 23:47.
7. Apostolski S., McAlarney T., Quattrini A., et al. The gp120 glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons. Ann. Neurol. 1993, 34:855.
8. Authier F.J., Gherardi R.K. Peripheral neuropathies in HIV-infected patients in the era of HAART. Brain Pathol. 2003, 13:223.
9. + T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112.
10. Bacellar H., Munoz A., Miller E.N., et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology 1994, 44:1892.
11. Bailey R.O., Baltch A.L., Venkatesh R., et al. Sensory motor neuropathy associated with AIDS. Neurology 1988, 38:886.
12. Barohn R.J., Gronseth G.S., LeForce B.R., et al. Peripheral nervous system involvement in a large cohort of human immunodeficiency virus-infected individuals. Arch. Neurol. 1993, 50:167.
13. Behar R., Wiley C., McCutchan J.A. Cytomegalovirus polyradiculoneuropathy in acquired immune deficiency syndrome. Neurology 1987, 37:557.
14. Belec L., Gherardi R., Georges A.J., et al. Peripheral facial paralysis and HIV infection: report of four African cases and review of the literature. J. Neurol. 1989, 236:411.
15. Berger A.R., Arezzo J.C., Schaumburg H.H., et al. 2', 3'-Dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology 1993, 43:358.
16. Berger J.R., Difini J.A., Swerdloff M.A., et al. HIV seropositivity in Guillain-Barre syndrome. Ann. Neurol. 1987, 22:393.
17. Bishopric G., Bruner J., Butler J. Guillain-Barre syndrome with cytomegalovirus infection of peripheral nerves. Arch. Pathol. Lab. Med. 1985, 109:1106.
18. Blum A.S., Dal Pan G.J., Feinberg J., et al. Low-dose zalcitabine-related toxic neuropathy: frequency, natural history, and risk factors. Neurology 1996, 46:999.
19. Bozzette S.A., Richman D.D. Salvage therapy for zidovudine-intolerant HIV-infected patients with alternating and intermittent regimens of zidovudine and dideoxycytidine. Am. J. Med. 1990, 88:24S.
20. Brannagan T.H., Nuovo G.J., Hays A.P., et al. Human immunodeficiency virus infection of dorsal root ganglion neurons detected by polymerase chain reaction in situ hybridization. Ann. Neurol. 1997, 42:368.
21. Brannagan T.H., Zhou Y. HIV-associated Guillain-Barre syndrome. J. Neurol. Sci. 2003, 208:39.
22. Breen R.A., Lipman M.C., Johnson M.A. Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals. AIDS 2000, 14:615.
23. Brew B.J., Tisch S., Law M. Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy. AIDS 2003, 17:1094.
24. Brodt H.R., Kamps B.S., Gute P., et al. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 1997, 11:1731.
25. Calabrese L.H., Proffitt M.R., Levin K.H., et al. Acute infection with the human immunodeficiency virus (HIV) associated with acute brachial neuritis and exanthematous rash. Ann. Intern. Med. 1987, 107:849.
26. Calcutt N.A., Freshwater J.D., O'Brien J.S. Protection of sensory function and antihyperalgesic properties of a prosaposin-derived peptide in diabetic rats. Anesthesiology 2000, 93:1271.
27. Carey P. Peripheral neuropathy: zalcitabine reassessed. Int. J. STD AIDS 2000, 11:417.
28. Carne C.A., Tedder R.S., Smith A., et al. Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet 1985, 2:1206.
29. Chavanet P., Solary E., Giroud M., et al. Infraclinical neuropathies related to immunodeficiency virus infection associated with higher T-helper cell count. J. Acquir. Immune Defic. Syndr. 1989, 2:564.
30. Chavanet P.Y., Giroud M., Lancon J.P., et al. Altered peripheral nerve conduction in HIV-patients. Cancer Detect. Prev. 1988, 12:249.
31. Chen C.H., Vazquez-Padua M., Cheng Y.C. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity Mol. Pharmacol. 1991, 39:625.
32. Cherry C.L., Gahan M.E., McArthur J.C., et al. Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat. J. Acquir. Immune Defic. Syndr. 2002, 30:271.
33. Cherry C.L., McArthur J.C., Hoy J.F., et al. Nucleoside analogues and neuropathy in the era of HAART. J. Clin. Virol. 2003, 26:195.
34. Childs E.A., Lyles R.H., Selnes O.A., et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 1999, 52:607.
35. Cohen J.A., Laudenslager M. Autonomic nervous system involvement in patients with human immunodeficiency virus infection. Neurology 1989, 39:1111.
36. Conlon C.P. HIV infection presenting as Guillain-Barre syndrome in Lusaka, Zambia. Trans. R. Soc. Trop. Med. Hyg. 1989, 83:109.
37. Cooley T.P., Kunches L.M., Saunders C.A., et al. Once-daily administration of 2', 3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex: results of a Phase I trial. N. Engl. J. Med. 1990, 322:1340.
38. Cooper D.A., Gold J., Maclean P., et al. Acute AIDS retrovirus infection: definition of a clinical illness associated with seroconversion. Lancet 1985, 1:537.
39. Cornblath D.R., Griffin D.E., Welch D., et al. Quantitative analysis of endoneurial T-cells in human sural nerve biopsies. J. Neuroimmunol. 1990, 26:113.
40. Cornblath D.R., McArthur J.C. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 1988, 38:794.
41. Cornblath D.R., McArthur J.C., Kennedy P.G., et al. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann. Neurol. 1987, 21:32.
42. Cornblath D.R., Mellits E.D., Griffin J.W., et al. Motor conduction studies in Guillain-Barre syndrome: description and prognostic value. Ann. Neurol. 1988, 23:354.
43. Craddock C., Pasvol G., Bull R., et al. Cardiorespiratory arrest and autonomic neuropathy in AIDS. Lancet 1987, 2:16.
44. Crane L.R., Ebright J.R. Cytomegalovirus polyradicu-lopathy caused by a ganciclovir-resistant strain. Clin. Infect. Dis. 1994, 19:365.
45. Cruz Martinez A., Villoslada C. Electrophysiologic study in peripheral neuropathy associated with HIV infection. Electromyogr. Clin. Neurophysiol. 1991, 31:407.
46. Cui L., Locatelli L., Xie M.Y., et al. Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells. J. Pharmacol. Exp. Ther. 1997, 280:1228.
47. Cupps T.R., Fauci A.S. The Vasculitides 1981, W. B. Saunders, Philadelphia.
48. Dalakas M.C., Pezeshkpour G.H. Neuromuscular diseases associated with human immunodeficiency virus infection. Ann. Neurol. 1988, 23(Suppl.):S38.
49. Dalakas M.C., Semino-Mora C., Leon-Monzon M. Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neur-opathy induced by 2', 3'-dideoxycytidine (ddC). Lab. Invest. 2001, 81:1537.
50. de la Monte S.M., Gabuzda D.H., Ho D.D., et al. Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann. Neurol. 1988, 23:485.
51. Decker C.F., Tarver J.H., Murray D.F., et al. Prolonged concurrent use of ganciclovir and foscarnet in the treatment of polyradiculopathy due to cytomegalovirus in a patient with AIDS. Clin. Infect. Dis. 1994, 19:548.
52. Denning D.W. The neurological features of acute HIV infection. Biomed. Pharmacother. 1988, 42:11.
53. Denning D.W., Anderson J., Rudge P., et al. Acute myelopathy associated with primary infection with human immunodeficiency virus. Br. Med. J. (Clin. Res. Ed.) 1987, 294:143.
54. Dore G.J., Correll P.K., Li Y., et al. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 1999, 13:1249.
55. Dowling P.C., Cook S.D. Role of infection in Guillain-Barre syndrome: laboratory confirmation of herpesviruses in 41 cases. Ann. Neurol. 1981, 9(Suppl.):44.
56. Dubinsky R.M., Yarchoan R., Dalakas M., et al. Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2', 3'-dideoxycytidine (ddC). Muscle Nerve 1989, 12:856.
57. Dyck P.J., Benstead T.J., Conn D.L., et al. Nonsystemic vasculitic neuropathy. Brain 1987, 110:843. Pt. 4.
58. Eidelberg D., Sotrel A., Vogel H., et al. Progressive polyradiculopathy in acquired immune deficiency syndrome. Neurology 1986, 36:912.
59. Evenhouse M., Haas E., Snell E., et al. Hypotension in infection with the human immunodeficiency virus. Ann. Intern. Med. 1987, 107:598.
60. Famularo G., Moretti S., Marcellini S., et al. Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. AIDS 1997, 11:185.
61. Feldman D., Brosnan C., Anderson T.D. Ultrastructure of peripheral neuropathy induced in rabbits by 2', 3'-dideoxy-cytidine. Lab. Invest. 1992, 66:75.
62. Fialho, D., and Cornblath, D. R.: Treatment for human immunodeficiency virus-related distal symmetric polyneuropathy (Protocol for a Cochrane Review). Cochrane Database Syst. Rev. (in press).
63. Fichtenbaum C.J., Clifford D.B., Powderly W.G. Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995, 10:169.
64. + lymphocytosis syndrome in HIV-infected patients. AIDS Read. 2002, 12:408.
65. French M., Amin J., Roth N., et al. Randomized, openlabel, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 infection: the OzCombo 2 study. HIV Clin. Trials 2002, 3:177.
66. Fuller G.N., Gill S.K., Guiloff R.J., et al. Ganciclovir for lumbosacral polyradiculopathy in AIDS. Lancet 1990, 335:48.
67. Fuller G.N., Greco C.M., Miller R.G. Cytomegalovirus and mononeuropathy multiplex in AIDS. Neurology 1990, 40(Suppl. 1):301.
68. Fuller G.N., Jacobs J.M., Guiloff R.J. Association of painful peripheral neuropathy in AIDS with cytomegalovirus infection. Lancet 1989, 2:937.
69. Fuller G.N., Jacobs J.M., Guiloff R.J. Nature and incidence of peripheral nerve syndromes in HIV infection. J. Neurol. Neurosurg. Psychiatry 1993, 56:372.
70. Gastaut J.L., Gastaut J.A., Pellissier J.F., et al. Peripheral neuropathies in human immunodeficiency virus infection: a prospective study of 56 patients [in French]. Rev. Neurol. (Paris) 1989, 145:451.
71. Gherardi R., Lebargy F., Gaulard P., et al. Necrotizing vasculitis and HIV replication in peripheral nerves. N. Engl. J. Med. 1989, 321:685.
72. Gherardi R.K., Chretien F., Delfau-Larue M.H., et al. Neuropathy in diffuse infiltrative lymphocytosis syndrome: an HIV neuropathy, not a lymphoma. Neurology 1998, 50:1041.
73. Gold J.E., Jimenez E., Zalusky R. Human immunodeficiency virus-related lymphoreticular malignancies and peripheral neruologic disease: a report of four cases. Cancer 1988, 61:2318.
74. Grafe M.R., Wiley C.A. Spinal cord and peripheral nerve pathology in AIDS: the roles of cytomegalovirus and human immunodeficiency virus. Ann. Neurol. 1989, 25:561.
75. Graveleau P., Perol R., Chapman A. Regression of cauda equina syndrome in AIDS patient being treated with ganciclovir. Lancet 1989, 2:511.
76. Griffin D.W., McArthur J.C. Peripheral neuropathies associated with HIV infection. The Neurology of AIDS 1998, 275. Chapman & Hall, New York. H.E. Gendelman, L. Epstein, S. Swindels (Eds.).
77. Guillon J.M., Fouret P., Mayaud C., et al. Extensive T8-positive lymphocytic visceral infiltration in a homosexual man. Am. J. Med. 1987, 82(3):655. Spec. No.
78. Hagberg L., Malmvall B.E., Svennerholm L., et al. Guillain-Barre syndrome as an early manifestation of HIV central nervous system infection. Scand. J. Infect. Dis. 1986, 18:591.
79. Hall C.D., Snyder C.R., Messenheimer J.A., et al. Peripheral neuropathy in a cohort of human immunodeficiency virus-infected patients: incidence and relationship to other nervous system dysfunction. Arch. Neurol. 1991, 48:1273.
80. Herzberg U., Sagen J. Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis. J. Neuroimmunol. 2001, 116:29.
81. Ho D.D., Rota T.R., Schooley R.T., et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N. Engl. J. Med. 1985, 313:1493.
82. Ho D.D., Sarngadharan M.G., Resnick L., et al. Primary human T-lymphotropic virus type III infection. Ann. Intern. Med. 1985, 103(6):880. Pt. 1.
83. Hoke A., Keswani S.C., McArthur J. Current theraphy for HIV sensory neuropathy. Curr. Treatment Options Infect. Dis. 2003, 5:467.
84. Hughes R.A., Raphael J.C., Swan A.V., et al. Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst. Rev. 2001, 3:CD002063.
85. Ilyas A.A., Willison H.J., Quarles R.H., et al. Serum antibodies to gangliosides in Guillain-Barre syndrome. Ann. Neurol. 1988, 23:440.
86. Itescu S., Brancato L.J., Winchester R. A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet 1989, 2:466.
87. Itescu S., Winchester R. Diffuse infiltrative lymphocytosis syndrome: a disorder occurring in human immunodeficiency virus-1 infection that may present as a sicca syndrome. Rheum. Dis. Clin. North Am. 1992, 18:683.
88. Jacobson M.A., Mills J., Rush J., et al. Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis. Arch. Neurol. 1988, 45:1090.
89. Kazi S., Cohen P.R., Williams F., et al. The diffuse infiltrative lymphocytosis syndrome: clinical and immunogenetic features in 35 patients. AIDS 1996, 10:385.
90. Keilbaugh S.A., Prusoff W.H., Simpson M.V. The PC12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-1 dideoxynucleo-side analogs. Biochem. Pharmacol. 1991, 42:R5.
91. Kennedy, J. M., Hoke, A., Johnston, J. B., et al.: Peripheral neuropathy in feline immunodeficiency virus infection: evidence of inflammation and axonal injury. AIDS 2004 (in press).
92. Keppler O.T., Welte F.J., Ngo T.A., et al. Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J. Exp. Med. 2002, 195:719.
93. Keswani S.C., Chander B., Hasan C., et al. FK506 is neuroprotective in a model of antiretroviral toxic neuropathy. Ann. Neurol. 2003, 53:57.
94. Keswani S.C., Pardo C.A., Cherry C.L., et al. HIV-associated sensory neuropathies. AIDS 2002, 16:2105.
95. Keswani S.C., Polley M., Pardo C.A., et al. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann. Neurol. 2003, 54:287.
96. Kim Y.S., Hollander H. Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin. Infect. Dis. 1993, 17:32.
97. Kissel J.T., Riethman J.L., Omerza J., et al. Peripheral nerve vasculitis: immune characterization of the vascular lesions. Ann. Neurol. 1989, 25:291.
98. La Spina I., Porazzi D., Maggiolo F., et al. Gabapentin in painful HIV-related neuropathy: a report of 19 patients, preliminary observations. Eur. J. Neurol. 2001, 8:71.
99. Lambert J.S., Seidlin M., Reichman R.C., et al. 2', 3'-Dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex: a Phase I trial. N. Engl. J. Med. 1990, 322:1333.
100. Lange D.J., Britton C.B., Younger D.S., et al. The neuromuscular manifestations of human immunodeficiency virus infections. Arch. Neurol. 1988, 45:1084.
101. Lanska M.J., Lanska D.J., Schmidley J.W. Syphilitic polyradiculopathy in an HIV-positive man. Neurology 1988, 38:1297.
102. Leger J.M., Bolgert F., Bouche P., et al. The peripheral nervous system and HIV infection: 13 cases [in French]. Rev. Neurol. (Paris) 1988, 144:789.
103. Leger J.M., Bouche P., Bolgert F., et al. The spectrum of polyneuropathies in patients infected with HIV. J. Neurol. Neurosurg. Psychiatry 1989, 52:1369.
104. LeLacheur S.F., Simon G.L. Exacerbation of dideoxycytidine-induced neuropathy with dideoxyinosine. J. Acquir. Immune Defic. Syndr. 1991, 4:538.
105. Leport C., Chaunu M.P., Sicre J., et al. Peripheral neuropathy in relation to LAV/HTLV III retrovirus infection. A clinical, anatomical and immunological study: 5 cases [in French]. Presse Med. 1987, 16:55.
106. Levy R.M., Bredesen D.E., Rosenblum M.L. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J. Neurosurg. 1985, 62:475.
107. Lin-Greenberg A., Taneja-Uppal N. Dysautonomia and infection with the human immunodeficiency virus. Ann. Intern. Med. 1987, 106:167.
108. Lipkin W.I., Parry G., Kiprov D., et al. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology 1985, 35:1479.
109. Lohmoller G., Matuschke A., Goebel F.D. Falsepositive test of autonomic neuropathy in HIV infection and AIDS? Case control study of heart rate variability in 62 HIV positive patients [in German]. Med. Klin. 1989, 84:242.
110. Luciano C.A., Pardo C.A., McArthur J.C. Recent developments in the HIV neuropathies. Curr. Opin. Neurol. 2003, 16:403.
111. Mahadevan A., Gayathri N., Taly A.B., et al. Vasculitic neuropathy in HIV infection: a clinicopathological study. Neurol. India 2001, 49:277.
112. Mahieux F., Gray F., Fenelon G., et al. Acute myeloradi-culitis due to cytomegalovirus as the initial manifestation of AIDS. J. Neurol. Neurosurg. Psychiatry 1989, 52:270.
113. Mankowski J.L., Clements J.E., Zink M.C. Searching for clues: tracking the pathogenesis of human immunodeficiency virus central nervous system disease by use of an accelerated, consistent simian immunodeficiency virus macaque model. J. Infect. Dis. 2002, 186(Suppl. 2):S199.
114. Martin C., Solders G., Sonnerborg A., et al. Antiretroviral therapy may improve sensory function in HIV-infected patients: a pilot study. Neurology 2000, 54:2120.
115. McArthur J.C., Yiannoutsos C., Simpson D.M., et al. A Phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291. Neurology 2000, 54:1080.
116. McDougal J.S., Hubbard M., Nicholson J.K., et al. Immune complexes in the acquired immunodeficiency syndrome (AIDS): relationship to disease manifestation, risk group, and immunologic defect. J. Clin. Immunol. 1985, 5:130.
117. Mehndiratta M.M., Hughes R.A. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst. Rev. 2002, 3:CD002062.
118. Mehndiratta, M. M., Hughes, R. A., and Agarwal, P.: Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst. Rev. (in press).
119. Mendell J.R., Sahenk Z. Clinical practice: painful sensory neuropathy. N. Engl. J. Med. 2003, 348:1243.
120. Meng T.C., Fischl M.A., Richman D.D. AIDS Clinical Trials Group: Phase I/II study of combination 2', 3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex. Am. J. Med. 1990, 88:27S.
121. Merigan T.C., Skowron G. Safety and tolerance of dideoxycytidine as a single agent: results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. Am. J. Med. 1990, 88:11S.
122. Merigan T.C., Skowron G., Bozzette S.A., et al. Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections: a Phase I and II study. Ann. Intern. Med. 1989, 110:189.
123. Miller R.F., Semple S.J. Autonomic neuropathy in AIDS. Lancet 1987, 2:343.
124. Miller R.G., Parry G.J., Pfaeffl W., et al. The spectrum of peripheral neuropathy associated with ARC and AIDS. Muscle Nerve 1988, 11:857.
125. Miller R.G., Storey J.R., Greco C.M. Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology 1990, 40:569.
126. Milligan E.D., Mehmert K.K., Hinde J.L., et al. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res. 2000, 861:105.
127. Milligan E.D., O'Connor K.A., Nguyen K.T., et al. Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J. Neurosci. 2001, 21:2808.
128. Mocroft A., Katlama C., Johnson A.M., et al. AIDS across Europe, 1994-98: the EuroSIDA study. Lancet 2000, 356:291.
129. Moore R.D., Chaisson R.E. Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 1999, 13:1933.
130. Moore R.D., Wong W.M., Keruly J.C., et al. Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS 2000, 14:273.
131. Moskowitz L.B., Gregorios J.B., Hensley G.T., et al. Cytomegalovirus: induced demyelination associated with acquired immune deficiency syndrome. Arch. Pathol. Lab. Med. 1984, 108:873.
132. Moulignier A., Authier F.J., Baudrimont M., et al. Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann. Neurol. 1997, 41:438.
133. Mouton Y., Alfandari S., Valette M., et al. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Federation National des Centres de Lutte contre le SIDA. AIDS 1997, 11:F101.
134. Moyle G. Clinical manifestations and management of anti-retroviral nucleoside analog-related mitochondrial toxicity. Clin. Ther. 2000, 22:911. discussion 898.
135. Murray H.W., Squires K.E., Weiss W., et al. Stavudine in patients with AIDS and AIDS-related complex. AIDS Clinical Trials Group 089. J. Infect. Dis. 1995, 171(Suppl. 2):S123.
136. Newshan G. HIV neuropathy treated with gabapentin. AIDS 1998, 12:219.
137. Oh S.B., Tran P.B., Gillard S.E., et al. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J. Neurosci. 2001, 21:5027.
138. Paice J.A., Ferrans C.E., Lashley F.R., et al. Topical capsaicin in the management of HIV-associated peripheral neuropathy. J. Pain Symptom Manage. 2000, 19:45.
139. Pardo C.A., McArthur J.C., Griffin J.W. HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J. Peripher. Nerv. Syst. 2001, 6:21.
140. Parry G.J. Peripheral neuropathies associated with human immunodeficiency virus infection. Ann. Neurol. 1988, 23(Suppl.):S49.
141. Periquet M.I., Novak V., Collins M.P., et al. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 1999, 53:1641.
142. Persuy P., Arnott G., Fortier B., et al. Guillain-Barre syndrome with favorable outcome in a case of recent human immunodeficiency virus infection [in French]. Rev. Neurol. (Paris) 1988, 144:32.
143. Piette A.M., Tusseau F., Vignon D., et al. Acute neuropathy coincident with seroconversion for anti-LAV/HTLV-III. Lancet 1986, 1:852.
144. Pizzo P.A. Treatment of human immunodeficiency virus-infected infants and young children with dideoxynucleo-sides. Am. J. Med. 1990, 88:16S.
145. Polydefkis M., Yiannoutsos C.T., Cohen B.A., et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 2002, 58:115.
146. Przedborski S., Liesnard C., Voordecker P., et al. Inflammatory demyelinating polyradiculoneuropathy associated with human immunodeficiency virus infection. J. Neurol. 1988, 235:359.
147. Rance N.E., McArthur J.C., Cornblath D.R., et al. Gracile tract degeneration in patients with sensory neuropathy and AIDS. Neurology 1988, 38:265.
148. Raphael J.C., Chevret S., Hughes R.A., et al. Plasma exchange for Guillain-Barre syndrome. Cochrane Database Syst. Rev. 2002, 3:CD001798.
149. Rathbun R.C., Martin E.S. Didanosine therapy in patients intolerant of or failing zidovudine therapy. Ann. Pharmacother. 1992, 26:1347.
150. Rickert C.H., Evers S., Heese C., et al. Immunoglobulin deposition in sural nerves of AIDS patients with distal-symmetric HIV-associated polyneuropathy. Eur. J. Med. Res. 2002, 7:472.
151. Rizzuto N., Cavallaro T., Monaco S., et al. Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy. Acta Neuropathol. (Berl.) 1995, 90:244.
152. Rossero R., Asmuth D.M., Grady J.J., et al. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature. Int. J. STD AIDS 2003, 14:350.
153. Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J. Neurovirol. 2002, 8(Suppl. 2):115.
154. Said G., Lacroix C., Andrieu J.N. Necrotizing arteritis in patients with inflammatory neuropathy and human immunodeficiency virus (HIV-III) infection. Neurology 1987, 37(Suppl. 1):176.
155. Said G., Lacroix-Ciaudo C., Fujimura H., et al. The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann. Neurol. 1988, 23:461.
156. Schaumberg H.H., Spencer P.S., Thomas P.K. Disorders of Peripheral Nerves 1983, F. A. Davis, Philadelphia.
157. Schifitto G., McDermott M.P., McArthur J.C., et al. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology 2002, 58:1764.
158. Shlay J.C., Chaloner K., Max M.B., et al. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. JAMA 1998, 280:1590.
159. Simpson D.M. Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy. J. Neurovirol. 2002, 8(Suppl. 2):33.
160. Simpson D.M., Haidich A.B., Schifitto G., et al. Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS 2002, 16:407.
161. Simpson D.M., Katzenstein D., Haidich B., et al. Plasma carnitine in HIV-associated neuropathy. AIDS 2001, 15:2207.
162. Simpson D.M., McArthur J.C., Olney R., et al. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology 2003, 60:1508.
163. Simpson D.M., Olney R., McArthur J.C., et al. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology 2000, 54:2115.
164. Simpson D.M., Tagliati M. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995, 9:153.
165. Skowron G. Biologic effects and safety of stavudine: overview of Phase I and II clinical trials. J. Infect. Dis. 1995, 171(Suppl. 2):S113.
166. Skuta G., Fischer G.M., Janaky T., et al. Molecular mechanism of the short-term cardiotoxicity caused by 2', 3'-dideoxycytidine (ddC): modulation of reactive oxygen species levels and ADP-ribosylation reactions. Biochem. Pharmacol. 1999, 58:1915.
167. Smith I.L., Shinkai M., Freeman W.R., et al. Polyradiculopathy associated with ganciclovir-resistant cytomegalovirus in an AIDS patient: phenotypic and geno-typic characterization of sequential virus isolates. J. Infect. Dis. 1996, 173:1481.
168. Smith K.M., Crandall K.A., Kneissl M.L., et al. PCR detection of host and HIV-1 sequences from archival brain tissue. J. Neurovirol. 2000, 6:164.
169. So Y.T., Olney R.K. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann. Neurol. 1994, 35:53.
170. Starnes M.C., Cheng Y.C. Cellular metabolism of 2', 3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro. J. Biol. Chem. 1987, 262:988.
171. Thornton C.A., Latif A.S., Emmanuel J.C. Guillain-Barre syndrome associated with human immunodeficiency virus infection in Zimbabwe. Neurology 1991, 41:812.
172. Tokumoto J.I., Hollander H. Cytomegalovirus polyradiculopathy caused by a ganciclovir-resistant strain. Clin. Infect. Dis. 1993, 17:854.
173. Tucker T., Dix R.D., Katzen C., et al. Cytomegalovirus and herpes simplex virus ascending myelitis in a patient with acquired immune deficiency syndrome. Ann. Neurol. 1985, 18:74.
174. Van Schaik I.N., Winer J.B., de Haan R., et al. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst. Rev. 2002, 3:CD001797.
175. Vendrell J., Heredia C., Pujol M., et al. Guillain-Barre syndrome associated with seroconversion for anti-HTLV-III. Neurology 1987, 37:544.
176. Villa A., Foresti V., Confalonieri F. Autonomic neuropathy and HIV infection. Lancet 1987, 2:915.
177. Villa A., Foresti V., Confalonieri F. Autonomic nervous system dysfunction associated with HIV infection in intravenous heroin users. AIDS 1992, 6:85.
178. Villa A., Foresti V., Confalonieri F. Autonomic neuropathy and prolongation of QT interval in human immunodeficiency virus infection. Clin. Auton. Res. 1995, 5:48.
179. Walsh C.M., Nardi M.A., Karpatkin S. On the mechanism of thrombocytopenic purpura in sexually active homosexual men. N. Engl. J. Med. 1984, 311:635.
180. Wechsler A.F, Ho D.D. Bilateral Belľs palsy at the time of HIV seroconversion. Neurology 1989, 39:747.
181. Wiley C.A. Neuromuscular diseases of AIDS. FASEB J. 1989, 3:2503.
182. Williams D., Geraci A., Simpson D.D. AIDS and AIDS-treatment neuropathies. Curr. Pain Headache Rep. 2002, 6:125.
183. Winer J.B., Bang B., Clarke J.R., et al. A study of neuropathy in HIV infection. Q. J. Med. 1992, 83:473.
184. Wiselka M.J., Nicholson K.G., Ward S.C., et al. Acute infection with human immunodeficiency virus associated with facial nerve palsy and neuralgia. J. Infect. 1987, 15:189.
185. Wrzolek M.A., Rao C., Kozlowski P.B., et al. Muscle and nerve involvement in AIDS patient with disseminated Mycobacterium avium intracellulare infection. Muscle Nerve 1989, 12:247.
186. Yarchoan R., Perno C.F., Thomas R.V., et al. Phase I studies of 2', 3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet 1988, 1:76.
187. Yoshioka M., Shapshak P., Srivastava A.K., et al. Expression of HIV-1 and interleGBRin-6 in lumbosacral dorsal root ganglia of patients with AIDS. Neurology 1994, 44:1120.
188. Zink M.C., Clements J.E. A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease. J. Neurovirol. 2002, 8(Suppl. 2):42.